Home » Newsletters » BioWorld Asia

BioWorld Asia

July 8, 1998

View Archived Issues

TAB Raises US$3M To Regroup; Ends Sepsis Trial To Cut Costs

Parasite Study Shows Importance Of Controlling Immune Response

Euro Officials Face Challenge To Improve Biotech Image

German Firm Opens Virtual Lab With A Click Of The Mouse

European Union Takes Action On Policy Failings By States

Circadian Spin-Off To Target Anti-Obesity Drug In US Trials

UK Aims To Keep Lead In Cloning With PPL Grant

Oxford Molecular Invests £2.5M In MicroGenics For Antibiotics

Other News To Note

Today's news in brief
BioWorld
BioWorld briefs for Jan. 13, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for January 13, 2025
Caplyta star shines as J&J takes Intra-Cellular in $14.6B deal
BioWorld
The J.P. Morgan (JPM) Healthcare Conference in San Francisco kicked off with a resounding bang as Johnson & Johnson (J&J) disclosed plans to acquire...
Proteomics study explores how protein changes influence disease
BioWorld Science
Fourteen global pharma companies are getting together to conduct the largest proteomics study to date, analyzing 600,000 blood samples held in the UK Biobank to...
Type 1 diabetes breakthrough? Sana threads key ‘islet,’ SC-451 to advance
BioWorld
Sana Biotechnology Inc. CEO Steve Harr said “cool and transformative science” led to his firm’s latest strides in type 1 diabetes, and the “very generalizable...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.